Indapamidă Terapia

Indapamide, the active ingredient in Indapamidă Terapia, is a thiazide-like diuretic presented as an oral dosage form for oral use. It is employed to manage high blood pressure and to reduce fluid accumulation in patients with heart‑related edema.

GNH USA supplies Indapamidă Terapia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide is a thiazide‑like diuretic that acts on the renal distal convoluted tubule to control fluid balance and vascular resistance.

- Hypertension: helps lower elevated blood pressure in primary and secondary hypertension. - Edema associated with congestive heart failure: promotes sodium and water excretion to reduce swelling and improve symptoms.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased frequency of urination - Electrolyte disturbances, especially low potassium - Fatigue - Nausea

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance - Hyponatremia (low blood sodium) - Hyperuricemia or gout attacks - Allergic reactions such as rash or angioedema - Blood dyscrasias (e.g., leukopenia, thrombocytopenia)

Before initiating therapy, clinicians should consider several safety measures.

- Monitor electrolytes: check serum potassium and sodium regularly. - Assess renal function: evaluate creatinine and eGFR before and during treatment. - Avoid abrupt discontinuation: taper dose to prevent sudden blood‑pressure spikes. - Use caution in diabetes: monitor blood‑glucose as diuresis may affect glycaemic control. - Use caution in gout: indapamide can raise uric acid levels. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Lithium: may increase lithium toxicity. - NSAIDs (e.g., ibuprofen, naproxen): can reduce diuretic effect and impair renal function. - ACE inhibitors or ARBs: combined use may cause excessive hypotension or renal impairment.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: diuretic‑induced changes in glucose may require dose adjustment. - Digoxin: increased serum digoxin levels may occur. - Warfarin: indapamide may enhance anticoagulant effect, requiring INR monitoring.